The reactivation of the ID proteins, particularly ID1, promotes the development of several tumor types, including high-grade astrocytoma, prostate and breast cancers and non-small cell lung carcinoma (14–17). This evidence concerns the gene ID1 and astrocytoma (excluding glioblastoma).